Vol. 2, No. 7 April 3, 2019
Cancer Institute Member Spotlight
Brian Koss
Ph.D. Candidate
UAMS College of Medicine
Graduate Program in Interdisciplinary Biomedical Sciences
|
|
|
|
|
Koss' research focuses on identifying new approaches to combat the metabolic suppression of an immune response in solid tumors. More specifically, he aims to mechanistically define epigenetically controlled metabolic stress responses in T cells during tumor infiltration. Read more>
|
|
|
Request for KL2 Career
Development Applications
The UAMS Translational Research Institute (TRI) offers a unique mentored career development opportunity for early career UAMS faculty. The KL2 Scholars Program is a two-year program of intensive mentored training in clinical and/or translational science and an innovative educational curriculum.
This year, for the first time, the Cancer Institute will partner with the TRI KL2 program to offer an additional KL2 award specifically for an investigator conducting breast cancer research.
KL2 Scholars receive:
- Salary support of up to $95,000/year for two years (includes fringe)
- Up to $25,000/year for two years for non-salary support to be used for research, tuition, travel expenses, educational materials or other costs related to the scholar's research
In return, the KL2 Scholar must dedicate a minimum of 75% effort to the program. The scholar’s home department or college must agree to provide salary supplementation to accommodate the 75% KL2 effort if needed.
The Cancer Institute encourages all early career cancer researchers to apply.
Click here for KL2 application information and instructions.
Click here to learn more about the KL2 program.
Click here to learn more about past KL2 Scholars.
|
|
|
Ronda Henry-Tillman, M.D., was named recipient of the Dr. David Bourne Leading Light Award by the Arkansas Cancer Coalition during the 20th Annual Arkansas Cancer Summit held March 27-28.
|
|
|
Donald J. Johann Jr., M.D., received an Outstanding Reviewer Award from Experimental Biology and Medicine (EBM). The award is presented to reviewers who receive the best scores from EBM editors and associate editors for the quality and timeliness of their reviews.
|
|
|
|
The Cancer Letter and AACI Update (click "Research Highlights" section to view) recently highlighted a study led by Brendan C. Stack Jr., M.D., showing the potential to alter neck dissection surgery in head and neck cancer patients. The study was published Feb. 15, 2019, in the Journal of Clinical Oncology.
|
|
|
Research Calendar
Be sure to check the research calendar on the Cancer Institute's website for upcoming events and funding opportunities.
|
Correction
In our last issue, the email address for Richard Owen, M.D., was listed incorrectly in the story titled "Research Grants Available at the VA." Dr. Owen's correct email address is Richard.Owen2@va.gov.
|
|
|
|
